Common side effects (nausea, constipation, appetite suppression) are identical to branded GLP-1s and typically subside within 24 weeks
It is not something your employer, your doctor, or your insurance company will ever run
Some people do just fine and see the effects they're looking for on the introductory 0.25 mg dose or on the first main phase of 0.5 mg doses
Its Phase 3 GLORY-2 trial showed 20.1% weight loss at 60 weeks, and the DREAMS-3 trial demonstrated head-to-head superiority over semaglutide 1 mg
Periodize intake rotate two or three higher-calorie refeed days to keep thyroid hormones stable
These tablets are designed to support appetite management, metabolic health, and medically supervised weight loss in a convenient once-daily oral dissolving tablet format